Menu

Filtros : "BMS" Removido: "2017" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database (2024)

    Baliga, Sujith; Abou-foul, Ahmad K; Parente, Pablo; Szturz, Petr; Thariat, Juliette; Shreenivas, Aditya; Nankivell, Paul; Bertolini, Federica; Biau, Julian; Kowalski, Luiz Paulo

    Source: European journal of cancer. Unidade: FM

    Subjects: NEOPLASIAS, RADIOTERAPIA, NEOPLASIAS DE CABEÇA E PESCOÇO, CONSENSO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BALIGA, Sujith et al. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. European journal of cancer, v. 203, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/76775. Acesso em: 27 nov. 2025.

    • APA

      Baliga, S., Abou-foul, A. K., Parente, P., Szturz, P., Thariat, J., Shreenivas, A., et al. (2024). Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database. European journal of cancer, 203. doi:10.1016/j.ejca.2024.114038

    • NLM

      Baliga S, Abou-foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Kowalski LP. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database [Internet]. European journal of cancer. 2024 ; 203[citado 2025 nov. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76775

    • Vancouver

      Baliga S, Abou-foul AK, Parente P, Szturz P, Thariat J, Shreenivas A, Nankivell P, Bertolini F, Biau J, Kowalski LP. Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database [Internet]. European journal of cancer. 2024 ; 203[citado 2025 nov. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/76775

  • Artigo de periodico

    Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)

    Giugliano, Robert P.; Nicolau, Jose Carlos

    Source: Circulation. Unidade: FM

    Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 27 nov. 2025.

    • APA

      Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950

    • NLM

      Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950

    • Vancouver

      Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2025 nov. 27 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025